Stay updated on Pembrolizumab Skin Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Skin Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0. No adjustments to study details, eligibility criteria, or results are evident.
    Difference
    0.1%
    Check dated 2026-03-21T08:30:38.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.4.3 update applied, replacing v3.4.2. This is a minor version update with no changes to the study information or user-facing features.
    Difference
    0.1%
    Check dated 2026-03-06T22:11:33.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T13:18:49.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0 as the page's version label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T23:32:31.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No clinical trial content, eligibility criteria, or outcome measures appear to be altered.
    Difference
    0.1%
    Check dated 2026-01-15T04:32:52.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    Added a Locations section listing Georgia (Atlanta, Emory University/Winship Cancer Institute) as a study site. Removed the previous Georgia Locations heading and the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-24T14:46:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Skin Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.